Showing results (61-70 of 160) with videos related to
Sort By:
Pageof 16
Frontiers in Cell and Developmental Biology|July 29, 2021
Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer TherapyAli Hassanzadeh, Amjad Hussein Altajer, Heshu Sulaiman Rahman, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemiaMarco Zecca, Luisa Strocchio, Daria Pagliara, et al.Haematologica|April 4, 2020
Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantationVolker Wiebking, Ciaran M Lee, Nathalie Mostrel, et al.BMC Cancer|April 25, 2018
Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticlesShu-Ta Wu, Anthony J Fowler, Corey B Garmon, et al.Blood|August 14, 2014
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALLLena Oevermann, Sebastian U Michaelis, Markus Mezger, et al.BMC Infectious Diseases|September 12, 2014
An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in ItalyMarta Ciofi Degli Atti, Paola Bernaschi, Michaela Carletti, et al.Cytotherapy|March 25, 2022
An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomesAlice Bertaina, Allistair Abraham, Carmem Bonfim, et al.Experimental Hematology|March 9, 2010
Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patientsGiovanni Caocci, Roberto Baccoli, Adriana Vacca, et al.Cytotherapy|June 10, 2025
Immune Monitoring after Cell Therapy and Hematopoietic Cell Transplantation: Guidelines by the ISCT Stem Cell Engineering CommitteeLinda Oppizzi, Kinga Hosszu, Susan Prockop, et al.Cancer Science|May 29, 2021
CAR-NK cell in cancer immunotherapy; A promising frontierFaroogh Marofi, Omar F Abdul-Rasheed, Heshu Sulaiman Rahman, et al.Pageof 16